Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
All >

News > Collaborations

Find below news about collaborations, licenses, supplies in Europe and Israel or including organisations from these regions.

Total search results: 4833 | Ordered by Date (descending)
1 2 3 ... 47 48 49  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Enterome S.A.. (9/23/20). "Press Release: Enterome Announces First Patient Dosed in Phase 2a Trial of Sibofimloc in Crohn’s Disease". Paris & Cambridge, MA. 2020-09-23
Boehringer Ingelheim. (9/17/20). "Press Release: Boehringer Ingelheim and Mirati Therapeutics Annonce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor". Ingelheim & San Di 2020-09-17
BioNTech SE. (9/17/20). "Press Release: BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021". Mainz. 2020-09-17
Moderna, Inc.. (9/16/20). "Press Release: Moderna Announces First Commercial Organization Outside North America in Switzerland". Cambridge, MA. 2020-09-16
BioNTech SE. (9/15/20). "Press Release: BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162". Mainz. 2020-09-15
Evotec SE. (9/14/20). "Press Release: Evotec and BIOASTER Partner to Build a Technology and Innovation Hub in Lyon". Hamburg. 2020-09-14
4SC AG. (9/11/20). "Press Release: 4SC and Maruho Discontinue Collaboration for Development of 4SC’s Kv1.3 Inhibitors". Planegg-Martinsried. 2020-09-11
Gain Therapeutics, Inc.. (9/10/20). "Press Release: Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program". Bethesda, MD. 2020-09-10
Bayer AG. (9/9/20). "Press Release: Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases". Berlin & Salt Lake City, UT. 2020-09-09
Evonetix Ltd.. (9/9/20). "Press Release: Evonetix and Analog Devices Collaborate onThird-Generation DNA Synthesis Platform". Cambridge. 2020-09-09
Intravacc B.V.. (9/8/20). "Press Release: Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine". Bilthoven. 2020-09-08
PhoreMost Ltd.. (9/8/20). "Press Release: PhoreMost and XtalPi Sign AI-based Pharmaceutical drug Discovery Collaboration Agreement". Cambridge & Cambridge, MA. 2020-09-08
CN Bio Innovations Ltd.. (9/8/20). "Press Release: CN Bio and Imperial College London Collaborate to Identify Novel Treatments for Alcoholic Hepatitis ". Cambridge & London. 2020-09-08
Boehringer Ingelheim. (9/7/20). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for Diabetic Retinopathy". Ingelheim & Sydney. 2020-09-07
Evotec SE. (9/2/20). "Press Release: Evotec Expands Its Proprietary Patient Database into Liver Disease with Unique Access to QUOD Biobank". Hamburg. 2020-09-02
BiomX Inc.. (9/2/20). "Press Release: BiomX Enters Collaboration with Boehringer Ingelheim with the Goal of Discovering Microbiome-Based Biomarkers for Inflammatory Bowel Disease". Ness Ziona. 2020-09-02
Biocartis Group N.V.. (9/1/20). "Press Release: Biocartis Expands Collaboration with LifeArc". Mechelen & London. 2020-09-01
Oxford BioMedica plc. (9/1/20). "Press Release: Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222". Oxford. 2020-09-01
Addex Therapeutics S.A.. (8/27/20). "Press Release: Addex and the SIB Swiss Institute of Bioinformatics Receive Innosuisse Grant to Repurpose Potent Dopamine Antagonist Using Computational Modelling". Geneva. 2020-08-27
Autifony Therapeutics Ltd.. (8/26/20). "Press Release: Autifony Therapeutics Regains Rights to Clinical Stage Kv3 Programme". Stevenage. 2020-08-26
Engitix Ltd.. (8/25/20). "Press Release: Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases". London. 2020-08-25
Bruker Corporation. (8/24/20). "Press Release: Bruker and Purity-IQ Sign Partnership Agreement to Transform the Cannabis Regulatory Landscape". Billerica, MA. 2020-08-24
Bayer AG. (8/24/20). "Press Release: Bayer and Informed Data Systems Inc. (One Drop) Join Forces to Jointly Develop Digital Health Products across Therapeutic Areas". Berlin. 2020-08-24
Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen. 2020-08-19
Evotec SE. (8/18/20). "Press Release: Evotec and Novo Nordisk Form Strategic Alliance to Develop Novel Therapies for Kidney Diseases". Hamburg. 2020-08-18
Hua Medicine (Shanghai) Ltd.. (8/17/20). "Press Release: Bayer and Hua Medicine Announce Commercialization Agreement and Strategic Partnership for Investigational First-in-Class Novel Diabetes Treatment Dorzagliatin in China". Beijing & Shanghai. 2020-08-17
Galapagos N.V.. (8/12/20). "Press Release: Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease". Mechelen & Boston, MA. 2020-08-12
Inveox GmbH. (8/10/20). "Press Release: Roche Diagnostics Germany and Inveox Jointly Drive Digital Solutions in Histopathology". Mannheim & Garching. 2020-08-10
Evotec SE. (8/5/20). "Press Release: Evotec and Secarna Pharmaceuticals Form Strategic Partnership in the Field of Antisense Therapy". Hamburg & Marburg. 2020-08-05
Redx Pharma plc. (8/4/20). "Press Release: Redx Signs Out Licensing Agreement with AstraZeneca". Alderley Park. 2020-08-04
MorphoSys AG. (8/1/20). "Press Release: FDA Approves Monjuvi (tafasitamab-cxix) in Combination with Lenalidomide for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)". Planegg & Wilmington, DE. 2020-08-01
BioNTech SE. (7/31/20). "Press Release: BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo (cemiplimab) Combination in Melanoma". Mainz. 2020-07-31
BioNTech SE. (7/31/20). "Press Release: Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate". New York, NY & Mainz. 2020-07-31
Coulter Partners. (7/28/20). "Press Release: Coulter Partners Secures Chief Executive Officer for Optimapharm". 2020-07-28
Quantro Therapeutics GmbH. (7/21/20). "Press Release: Quantro Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform". Vienna. 2020-07-21
BioNTech SE. (7/21/20). "Press Release: Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data". Mainz & New York, NY. 2020-07-21
Tubulis GmbH. (7/21/20). "Press Release: Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates". Munich. 2020-07-21
Apollo Therapeutics Fund. (7/21/20). "Press Release: UCLB and Apollo Therapeutics Secure First Out-licensing Deal to Deerfield, a Leading U.S. Healthcare Investment Firm". London & New York, NY. 2020-07-21
BioNTech SE. (7/20/20). "Press Release: Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-20
CureVac AG. (7/20/20). "Press Release: GSK and CureVac Announce Strategic mRNA Technology Collaboration". 2020-07-20
Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. 2020-07-15
Roche. (7/14/20). "Press Release: Roche Collaborates with Blueprint Medicines to Bring a New Treatment to People with RET-altered Cancers". Basel. 2020-07-14
BioNTech SE. (7/13/20). "Press Release: Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2". New York, NY & Mainz. 2020-07-13
Eir Ventures. (7/10/20). "Press Release: New Nordic Life Science Venture Fund, Eir Ventures, Launched to Leverage the Untapped Potential of Health Care Innovation". Stockholm & Copenhagen. 2020-07-10
Kymera Therapeutics Inc.. (7/9/20). "Press Release: Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Advance Novel Protein Degrader Therapies to Patients". Cambridge, MA. 2020-07-09
Anergis S.A.. (7/9/20). "Press Release: Anergis and Virometix Announce Research Collaboration to Use Synthetic Virus-Like Particles for Ultra-Fast Allergy Immunotherapy". Epalinges. 2020-07-09
Kaiku Health. (7/8/20). "Press Release: Kaiku Health Expands Collaboration with Roche in Digital Patient Monitoring and Management". 2020-07-08
Kiadis Pharma N.V.. (7/8/20). "Press Release: Kiadis Licenses Previously Undisclosed Pre-clinical K-NK-cell Programs to Sanofi, with Total Potential Deal Value of €875 Million, plus Royalties". Amsterdam. 2020-07-08
Numab Therapeutics AG. (7/7/20). "Press Release: Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases". Wädenswil & Ingelheim. 2020-07-07
Mission Therapeutics Ltd.. (7/6/20). "Press Release: Mission Raises $15m and Expands its Relationship with Pfizer". Cambridge. 2020-07-06
Paion AG. (7/2/20). "Press Release: Paion Announces U.S. FDA Approval of Remimazolam (Byfavo) for the Induction and Maintenance of Procedural Sedation". Aachen. 2020-07-02
Lysogene S.A.. (7/1/20). "Press Release: Lysogene Announces a Research Collaboration with the Weizmann Institute of Science". Paris. 2020-07-01
BioNTech SE. (7/1/20). "Press Release: Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2". New York, NY & Mainz. 2020-07-01
Genespire S.r.l.. (6/30/20). "Press Release: Genespire and the San Raffaele Telethon Institute for Gene Therapy Announce Publication in Nature Biotechnology on Enhanced Gene Editing Technique in Hematopoietic Stem Cells". Milan. 2020-06-30
Uniqure N.V.. (6/24/20). "Press Release: Uniqure Announces License Agreement with CSL Behring to Commercialize Hemophilia B Gene Therapy". Lexington, MA & Amsterdam. 2020-06-24
Qiagen N.V.. (6/23/20). "Press Release: Qiagen Provides Information on Potential Capital Gain from Its Minority Investment in ArcherDX". Venlo. 2020-06-23
Scienion AG. (6/22/20). "Press Release: Accurate Spike-in of Circulating Tumor Cells into Blood Samples is Essential for Reliable Analysis in Oncology Applications". Berlin, Lyon & Seattle, WA. 2020-06-22
Valneva S.E.. (6/18/20). "Press Release: Valneva and Bavarian Nordic Announce Marketing and Distribution Partnership". Saint-Herblain. 2020-06-18
Lead Discovery Center GmbH. (6/18/20). "Pressemitteilung: Neue Forschungsinfrastruktur in Bochum – Center für systembasierte Antibiotikaforschung (CESAR) eröffnet". Dortmund & Bochum. 2020-06-18
GlaxoSmithKline plc. (6/16/20). "Press Release: Ideaya and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology". South San Francisco, CA & London. 2020-06-16
eTheRNA Immunotherapeutics N.V.. (6/16/20). "Press Release: eTheRNA Raises EUR 34 Million in Series B Financing to Accelerate Multiple mRNA Therapeutic Development Programs Through to Clinical Proof of Concept". Niel. 2020-06-16
Lead Discovery Center GmbH. (6/16/20). "Press Release: LDC and Qurient Launch Start-up QLi5 Therapeutics in Dortmund, Germany". Dortmund. 2020-06-16
Epsilen Bio S.r.l.. (6/15/20). "Press Release: Epsilen Bio Appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board. Company Announces Strategic Collaboration with SR-Tiget". Milan. 2020-06-15
Bavarian Nordic A/S. (6/12/20). "Press Release: Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen". Copenhagen. 2020-06-12
Egle Therapeutics S.A.S.. (6/11/20). "Press Release: Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies". Pa 2020-06-11
Genmab A/S. (6/10/20). "Press Release: Genmab and AbbVie Announce Broad Oncology Collaboration". Copenhagen & North Chicago, IL. 2020-06-10
Applied Process Company Ltd. (APC Ltd.). (6/10/20). "Press Release: Irish Company APC Partners with Australian Biotechnology Firm Vaxine to Accelerate the Development and Delivery of New Covid-19 Vaccine candidate". Dublin. 2020-06-10
Merck KGaA. (6/10/20). "Press Release: Merck and 10x Genomics Launch Powerful New Option for CRISPR Research". Darmstadt. 2020-06-10
Scienion AG. (6/9/20). "Press Release: Scienion and Randox Expand Collaboration to Transform High Throughput Biochip Manufacturing". Berlin & Crumlin. 2020-06-09
Evox Therapeutics Ltd.. (6/9/20). "Press Release: Evox Therapeutics Announces a Multi-target RNA Interference and Antisense Research Collaboration and License Agreement with Lilly". 2020-06-09
AiCuris Anti-infective Cures GmbH. (6/9/20). "Press Release: Royalty Pharma Acquires Partial Royalty Interest on Prevymis (Letermovir) from AiCuris Anti-infective Cures GmbH". New York, NY & Wuppertal. 2020-06-09
Oxford Biomedica plc. (6/8/20). "Press Release: Oxford Biomedica Signs Five Year Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre". Oxford. 2020-06-08
Valo Therapeutics Ltd.. (6/8/20). "Press Release: Valo Therapeutics Announces Board Appointment of Dr Mai-Britt Zocca". Oxford & Helsinki. 2020-06-08
Rigenerand S.r.l.. (6/2/20). "Press Release: Rigenerand Receives Regulatory Approval for Gene Therapy Production". Modena. 2020-06-02
Sanofi S.A.. (5/29/20). "Press Release: Sanofi Announces Closing of Regeneron Stock Sale". Paris. 2020-05-29
Sanofi S.A.. (5/27/20). "Press Release: Sanofi Announces Pricing of Regeneron Stock Offering". Paris. 2020-05-27
Rentschler Biopharma SE. (5/27/20). "Press Release: Rentschler Biopharma Extends Collaboration with Genmab to U.S. Facility". Laupheim & Milford, MA. 2020-05-27
Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ. 2020-05-26
Sanofi S.A.. (5/25/20). "Press Release: Sanofi Intends to Sell Its Equity Investment in Regeneron, Confirms No Change to Ongoing Collaboration". Paris. 2020-05-25
GlaxoSmithKline plc. (5/21/20). "Press Release: GSK Partners with Samsung Biologics to Secure Additional Manufacturing Capacity for Innovative Biopharmaceutical Portfolio". London & Songdo. 2020-05-21
Rentschler Biopharma SE. (5/19/20). "Press Release: Rentschler Biopharma Licenses Horizon Discovery's CHOSource Platform to Complement Cell Line Development Offering for Difficult-to-Express Proteins". Laupheim, Milford, MA & Cambridge. 2020-05-19
Dyne Therapeutics Inc.. (5/19/20). "Press Release: Dyne Therapeutics Accelerates Programs in Facioscapulohumeral Muscular Dystrophy (FSHD) with Exclusive Licensing of Technologies to Target Genetic Basis of FSHD and Expanded Scientific Advisory Board". W 2020-05-19
Syngulon S.A.. (5/16/20). "Press Release: Enzymicals and Syngulon Sign a Non-exclusive License Agreement on the Use of Syngulon’s Antibiotic Free Technology to Produce Enzymes". Seraing. 2020-05-16
Lava Therapeutics B.V.. (5/15/20). "Press Release: Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics". Utrecht. 2020-05-15
BaseLaunch (BaselArea.swiss). (5/15/20). "Press Release: Roche Becomes Founding Partner of BaseLaunch Phase II". Basel. 2020-05-15
Immunai. (5/14/20). "Press Release: Immunai Launches to Fully Map the Entire Immune System to Better Develop Immunotherapies and Cell Therapies". New York, NY. 2020-05-14
Genespire S.r.l.. (5/13/20). "Press Release: Genespire and SR-Tiget Announce Strategic Alliance for the Development of Transformative Gene Therapies for Genetic Diseases and Disclose Collaboration Focus". Milan. 2020-05-13
CellGenix GmbH. (5/13/20). "Press Release: Ori Biotech and CellGenix to Collaborate in Order to Promote Innovation within Closed-system, Cell and Gene Therapy Manufacturing". Freiburg & London. 2020-05-13
Idorsia Ltd.. (5/12/20). "Press Release: Neurocrine Biosciences Exercises Option to License Idorsia's Novel Treatment for Rare Pediatric Epilepsy". San Diego, CA & Allschwil. 2020-05-12
Optibrium Ltd.. (5/12/20). "Press Release: Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific". Cambridge & Santa Fe, NM. 2020-05-12
Dyno Therapeutics, Inc.. (5/11/20). "Press Release: Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology". Cambridge, MA. 2020-05-11
Apceth Biopharma GmbH. (5/11/20). "Press Release: Hitachi Chemical Advanced Therapeutics Solutions and apceth Biopharma GmbH Enter into Strategic Clinical and Commercial Manufacturing Agreements with bluebird bio". Allendale, NJ & Munich. 2020-05-11
CRISPR Therapeutics AG. (5/11/20). "Press Release: CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001 for the Treatment of Severe Hemoglobinopathies". Zug, Cambridge, MA 2020-05-11
Yumab GmbH. (5/7/20). "Press Release: Yumab Identifies Promising Candidate for Covid-19 Antibody Therapy". Braunschweig. 2020-05-07
BioNTech SE. (5/5/20). "Press Release: Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program". New York, NY & Mainz. 2020-05-05
Dentons. (5/5/20). "Press Release: Dentons Advises Biotech Company Pluristem on European Investment Bank Financing". Düsseldorf & Frankfurt a. M.. 2020-05-05
Exscientia Ltd.. (5/5/20). "Press Release: SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence". Menlo Park, CA & Oxford. 2020-05-05
Transgene S.A.. (5/4/20). "Press Release: Vaxxel Acquires Transgene’s DuckCelt-T17 Cell Line to Develop Industrial-scale Vaccines against Respiratory Viruses". Lyon & Strasbourg. 2020-05-04
Lonza Ltd.. (5/1/20). "Press Release: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) against Novel Coronavirus". Cambridge, MA & Basel. 2020-05-01
Valneva S.E.. (4/30/20). "Press Release: Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15". Saint-Herblain & New York, NY. 2020-04-30
1 2 3 ... 47 48 49  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top